Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (481-490 of 600) with videos related to

Pageof 60
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Scientific Reports|May 18, 2018
Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial SpondyloarthritisNicolas Rosine, Adrien Etcheto, Houria Hendel-Chavez, et al.
Rheumatology (Oxford, England)|May 13, 2017
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpADésirée van der Heijde, Maxime Dougados, Robert Landewé, et al.
Rheumatology (Oxford, England)|October 25, 2011
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritisMaxime Dougados, Walter P Maksymowych, Robert B M Landewé, et al.
Arthritis Care & Research|May 9, 2017
Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled StudyMaxime Dougados, Désirée van der Heijde, Joachim Sieper, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
Annals of the Rheumatic Diseases|September 11, 2009
Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritisMaxime Dougados, Sandrine Jousse-Joulin, Frederic Mistretta, et al.
Joint Bone Spine|August 10, 2013
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritisPeter P Cheung, Maxime Dougados, Vincent Andre, et al.
Joint Bone Spine|March 10, 2021
The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis - methodology and baseline characteristics of the populationJérémie Sellam, Emmanuel Maheu, Michel D Crema, et al.
Pageof 60

Showing results (481-490 of 600) with videos related to

Sort By:
Pageof 60
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Scientific Reports|May 18, 2018
Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial SpondyloarthritisNicolas Rosine, Adrien Etcheto, Houria Hendel-Chavez, et al.
Rheumatology (Oxford, England)|May 13, 2017
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpADésirée van der Heijde, Maxime Dougados, Robert Landewé, et al.
Rheumatology (Oxford, England)|October 25, 2011
Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|October 4, 2017
Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritisMaxime Dougados, Walter P Maksymowych, Robert B M Landewé, et al.
Arthritis Care & Research|May 9, 2017
Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled StudyMaxime Dougados, Désirée van der Heijde, Joachim Sieper, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
Annals of the Rheumatic Diseases|September 11, 2009
Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritisMaxime Dougados, Sandrine Jousse-Joulin, Frederic Mistretta, et al.
Joint Bone Spine|August 10, 2013
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritisPeter P Cheung, Maxime Dougados, Vincent Andre, et al.
Joint Bone Spine|March 10, 2021
The DIGICOD cohort: A hospital-based observational prospective cohort of patients with hand osteoarthritis - methodology and baseline characteristics of the populationJérémie Sellam, Emmanuel Maheu, Michel D Crema, et al.
Pageof 60